SK352000A3 - Piperazine derivatives, process for its preparation and pharmaceutical composition containing same - Google Patents

Piperazine derivatives, process for its preparation and pharmaceutical composition containing same Download PDF

Info

Publication number
SK352000A3
SK352000A3 SK35-2000A SK352000A SK352000A3 SK 352000 A3 SK352000 A3 SK 352000A3 SK 352000 A SK352000 A SK 352000A SK 352000 A3 SK352000 A3 SK 352000A3
Authority
SK
Slovakia
Prior art keywords
benzopyran
oxo
formula
group
butyl
Prior art date
Application number
SK35-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Henning Bottcher
Gerd Bartoszyk
Hartmut Greiner
Christoph Seyfried
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK352000A3 publication Critical patent/SK352000A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK35-2000A 1997-07-18 1998-06-29 Piperazine derivatives, process for its preparation and pharmaceutical composition containing same SK352000A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19730989A DE19730989A1 (de) 1997-07-18 1997-07-18 Piperazin-Derivate
PCT/EP1998/003956 WO1999003855A1 (de) 1997-07-18 1998-06-29 Piperazin-derivate

Publications (1)

Publication Number Publication Date
SK352000A3 true SK352000A3 (en) 2000-06-12

Family

ID=7836208

Family Applications (1)

Application Number Title Priority Date Filing Date
SK35-2000A SK352000A3 (en) 1997-07-18 1998-06-29 Piperazine derivatives, process for its preparation and pharmaceutical composition containing same

Country Status (23)

Country Link
US (1) US6251908B1 (no)
EP (1) EP0998474B1 (no)
JP (1) JP2001510193A (no)
KR (1) KR100528684B1 (no)
CN (1) CN1093127C (no)
AR (1) AR010932A1 (no)
AT (1) ATE353326T1 (no)
AU (1) AU731332B2 (no)
BR (1) BR9810607A (no)
CA (1) CA2296687A1 (no)
DE (2) DE19730989A1 (no)
ES (1) ES2281131T3 (no)
HU (1) HUP0002718A3 (no)
ID (1) ID24663A (no)
MY (1) MY132794A (no)
NO (1) NO20000216D0 (no)
PL (1) PL191078B1 (no)
RU (1) RU2194048C2 (no)
SK (1) SK352000A3 (no)
TW (1) TW425398B (no)
UA (1) UA59407C2 (no)
WO (1) WO1999003855A1 (no)
ZA (1) ZA986390B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK287018B6 (sk) * 1999-08-23 2009-09-07 Solvay Pharmaceuticals B. V. Deriváty fenylpiperazínov, spôsob ich prípravy, farmaceutická kompozícia s ich obsahom a ich použitie
AU1502702A (en) * 2000-11-14 2002-05-27 Merck Patent Gmbh Novel uses of combined 5-HT<sub>1A</sub> agonists and serotonin reuptake inhibitors
AR032712A1 (es) * 2001-02-21 2003-11-19 Solvay Pharm Bv Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen
DE10112151A1 (de) * 2001-03-14 2002-09-19 Merck Patent Gmbh Substituierte Benzofuran-2-carbonsäureamide
ATE424825T1 (de) 2001-07-20 2009-03-15 Psychogenics Inc Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
DE10217006A1 (de) * 2002-04-16 2003-11-06 Merck Patent Gmbh Substituierte Indole
DE10259244A1 (de) * 2002-12-17 2004-07-01 Merck Patent Gmbh N-(Indolethyl-)cycloamin-Verbindungen
DE10305739A1 (de) 2003-02-11 2004-08-19 Merck Patent Gmbh Benzofuranderivate
DE10315285A1 (de) * 2003-04-04 2004-10-14 Merck Patent Gmbh Chromenonindole
GT200600414A (es) * 2005-09-12 2007-09-20 Sal de glucuranato de compuesto de piperazine
US9066903B2 (en) 2006-02-28 2015-06-30 The United States Of America As Represented By The Department Of Veterans Affairs Pharmacological treatment of Parkinson's disease
US9447310B2 (en) 2008-04-17 2016-09-20 Thomas P. Daly Biological buffers with wide buffering ranges
US7939659B2 (en) * 2008-04-17 2011-05-10 Thomas Daly Biological buffers with wide buffering ranges
US8034951B2 (en) * 2008-04-17 2011-10-11 Thomas Daly Biological buffers with wide buffering ranges
US20170313920A1 (en) 2010-10-06 2017-11-02 Thomas P. Daly Biological Buffers with Wide Buffering Ranges
US7635791B2 (en) * 2008-04-17 2009-12-22 Tpat Ip Llc Biological buffers with wide buffering ranges
US8334402B2 (en) * 2008-04-17 2012-12-18 Thomas Daly Biological buffers with wide buffering ranges
US9090638B2 (en) 2008-04-17 2015-07-28 Thomas Daly Biological buffers with wide buffering ranges
US8519141B2 (en) 2008-04-17 2013-08-27 Thomas Daly Biological buffers with wide buffering ranges
US8822728B2 (en) 2008-04-17 2014-09-02 Thomas Daly Biological buffers with wide buffering ranges
EP2374459A1 (en) * 2008-05-30 2011-10-12 Psychogenics Inc. Treatment for neurological and mental disorders
EP2429579A1 (en) 2009-05-12 2012-03-21 Transgene SA Immortalized avian cell lines and use thereof
CN102206214B (zh) * 2011-04-07 2014-03-12 华中科技大学 苯并吡喃酮类衍生物及其应用
US9475754B2 (en) 2011-10-06 2016-10-25 Thomas P. Daly Biological buffers with wide buffering ranges
KR102151963B1 (ko) * 2012-05-23 2020-09-07 네르비아노 메디칼 사이언시스 에스.알.엘. N-[5-(3,5-디플루오로-벤질)-1h-인다졸-3-일]-4-(4-메틸-피페라진-1-일)-2-(테트라하이드로-피란-4-일아미노)-벤즈아미드의 제조 방법
EP3027607B1 (en) 2013-07-29 2020-08-26 Sunshine Lake Pharma Co., Ltd. Substituted heteroaryl compounds and methods of use thereof
CN105418506B (zh) * 2014-09-19 2018-04-24 上海医药工业研究院 乙酰苄胺哌嗪类衍生物及其作为脑神经保护剂的应用
US10316025B2 (en) 2015-06-03 2019-06-11 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB146691A (en) * 1919-05-29 1920-07-15 William Herbert Tripp Apparatus for indicating and recording side drift or leeway of aircraft
FR2189027B1 (no) * 1972-06-21 1976-03-05 Leurquin Laboratoires Fr
DE4333254A1 (de) * 1993-09-30 1995-04-06 Merck Patent Gmbh Piperidine und Piperazine
AU713573B2 (en) * 1996-07-26 1999-12-02 Nissan Chemical Industries Ltd. Chroman derivatives
DE69819173T2 (de) * 1997-07-25 2004-04-15 H. Lundbeck A/S Indole und 2,3-dihydroindolderivate, ihre herstellung und verwendung

Also Published As

Publication number Publication date
HUP0002718A2 (hu) 2001-10-28
JP2001510193A (ja) 2001-07-31
CA2296687A1 (en) 1999-01-28
RU2194048C2 (ru) 2002-12-10
BR9810607A (pt) 2000-07-11
NO20000216L (no) 2000-01-17
NO20000216D0 (no) 2000-01-17
CN1264379A (zh) 2000-08-23
ES2281131T3 (es) 2007-09-16
KR20010021957A (ko) 2001-03-15
CN1093127C (zh) 2002-10-23
PL338075A1 (en) 2000-09-25
MY132794A (en) 2007-10-31
AU731332B2 (en) 2001-03-29
DE19730989A1 (de) 1999-01-21
EP0998474A1 (de) 2000-05-10
ZA986390B (en) 1999-05-24
AR010932A1 (es) 2000-07-12
UA59407C2 (uk) 2003-09-15
US6251908B1 (en) 2001-06-26
HUP0002718A3 (en) 2001-11-28
ID24663A (id) 2000-07-27
TW425398B (en) 2001-03-11
AU8730298A (en) 1999-02-10
KR100528684B1 (ko) 2005-11-15
PL191078B1 (pl) 2006-03-31
WO1999003855A1 (de) 1999-01-28
ATE353326T1 (de) 2007-02-15
EP0998474B1 (de) 2007-02-07
DE59813899D1 (de) 2007-03-22

Similar Documents

Publication Publication Date Title
SK352000A3 (en) Piperazine derivatives, process for its preparation and pharmaceutical composition containing same
RU2132848C1 (ru) Производные пиперидина и пиперазина, способ их получения, содержащие их фармацевтические композиции и способ их получения
JP3327473B2 (ja) インドール誘導体
US5242925A (en) Piperazinylbenzodioxane derivatives
CA2147451C (en) 3-indolylpiperidines
SK30399A3 (en) D4 receptor selectivity piperazine derivatives
US6509340B1 (en) Amide and urea derivatives as 5-HT reuptake inhibitors and as 5-HT1B/1D ligands
SK281080B6 (sk) Derivát indolpiperidínu, spôsob jeho prípravy a farmaceutický prostriedok, ktorý ho obsahuje a jeho použitie
US6333339B1 (en) 3-Benzylpiperidine
CZ200077A3 (cs) Derivát piperazinu, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje
RU2211216C2 (ru) Производные амидов и мочевины в качестве ингибиторов вторичного поглощения 5-ht и лигандов 5-ht1b/1d
US20030064995A1 (en) Amide and urea derivatives as 5-HT reuptake inhibitors and as5-HT1B/1D ligands
CZ450999A3 (cs) Derivát 3-benzylpiperidinu, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje
MXPA00000615A (en) Piperazine derivatives
MXPA01006500A (es) Derivados de amida y urea como inhibidores de reabsorcion de 5-ht y como ligandos 5-ht1b/1d
KR20010112231A (ko) 5―ht 재흡수 저해제 및 5―ht1b/1d리간드로서의 아미드 및 우레아 유도체